Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / Common Stock, Par Value $0.0001 Per Share.
-
Shares outstanding
-
10,308,949
-
Number of holders
-
0
-
Total 13F shares, excl. options
-
0
-
Shares change
-
-292,762
-
Total reported value, excl. options
-
$0
-
Value change
-
-$118,780
-
Number of sells
-
-11
Significant Holders of Dermata Therapeutics, Inc. - Common Stock, Par Value $0.0001 Per Share. (DRMA) as of Q1 2023
11 filings reported holding DRMA - Dermata Therapeutics, Inc. - Common Stock, Par Value $0.0001 Per Share. as of Q1 2023.
Dermata Therapeutics, Inc. - Common Stock, Par Value $0.0001 Per Share. (DRMA) has 0 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 0 shares
of 10,308,949 outstanding shares and own 0% of the company stock.
Largest 10 shareholders include WELLS FARGO & COMPANY/MN (0 shares), Tudor Investment Corp Et Al (0 shares), MORGAN STANLEY (0 shares), HC Advisors, LLC (0 shares), GEODE CAPITAL MANAGEMENT, LLC (0 shares), UBS Group AG (0 shares), Tower Research Capital LLC (TRC) (0 shares), TWO SIGMA SECURITIES, LLC (0 shares), Raymond James Financial Services Advisors, Inc. (0 shares), and FAS Wealth Partners, Inc. (0 shares).
This table shows the top 0 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.